SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-16-784040
Filing Date
2016-12-02
Accepted
2016-12-02 17:26:54
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM S-3 d289117ds3.htm S-3 252887
2 EX-5.1 d289117dex51.htm EX-5.1 13393
3 EX-23.1 d289117dex231.htm EX-23.1 1635
4 GRAPHIC g289117g1201150806824.jpg GRAPHIC 2866
5 GRAPHIC g289117g33w77.jpg GRAPHIC 3953
6 GRAPHIC g289117g37y90.jpg GRAPHIC 2868
  Complete submission text file 0001193125-16-784040.txt   282778
Mailing Address 9380 JUDICIAL DRIVE SAN DIEGO CA 92121
Business Address 9380 JUDICIAL DRIVE SAN DIEGO CA 92121 858-210-3700
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-214897 | Film No.: 162032098
SIC: 8731 Services-Commercial Physical & Biological Research